Navigation Links
Synvista Therapeutics to Present at Acumen BioFin Rodman & Renshaw 5th Annual Global Healthcare Conference
Date:5/12/2008

uct candidates, and other risks identified in Synvista Therapeutics' filings with the Securities and Exchange Commission. Further information on risks faced by Synvista are detailed under the caption "Risk Factors" in Synvista Therapeutics' Annual Report on Form 10-K for the year ended December 31, 2007. These filings are available on a website maintained by the Securities and Exchange Commission at http://www.sec.gov. The information contained in this press release is accurate as of the date indicated. Actual results, events or performance may differ materially. Synvista Therapeutics undertakes no obligation to publicly release the result of any revision to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.


'/>"/>
SOURCE Synvista Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Synvista Therapeutics to Present at the BIO InvestorForum 2007
2. Synvista Therapeutics to be Featured on Wallst.net
3. Synvista Therapeutics to Develop Topical Formulation of ALT-2074 for the Treatment of Psoriasis
4. Synvista Therapeutics to Present at the 10th Annual BIO CEO & Investor Conference
5. Synvista Therapeutics Highlights Newly Published Data Demonstrating the Value of Haptoglobin Genotype Testing In People with Diabetes
6. Synvista Therapeutics Increases Commercial Focus by Appointing David C. Tantillo Senior Director of Marketing and Sales
7. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
8. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
9. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
10. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
11. Amsterdam Molecular Therapeutics to Release H1 2007 Results on August 29, 2007

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)... , ROCKVILLE, Md., Nov. 30 /PRNewswire-First...-stage vaccine company, announced today that the c...h Care Conference 2009 on December 2, 2009 at 12:3... Novavax will provide an overview of the company,s...ess and upcoming milestones. A link to the live a...
(Date:11/30/2009)... , ROCKVILLE, Md., Nov. 30 /PRNewswire-First...today it has completed enrollment in the Phase II ... (2008/2009 recommended strains) VLP vaccine candi...lder adults). This randomized, double-blind, acti...ability and immunogenicity of two different doses ...
(Date:11/30/2009)... , SHANGHAI, Nov. 30 /PRNewswire-Asi...rmaceutical, biotechnology, and medical-device res...rations in China and the United States,announced ...gy Fast 50 China,2009 list for the fifth consecuti...g companies in China,s technology, media, and tele...
(Date:11/27/2009)... , DURHAM, N.C., Nov. 27 /PRNewswire/ -...will initiate water-soluble carbon nanotube-based ...he water-soluble carbon nanotubes, which have func...tion with cancer drugs, was developed in partnersh...conjugated carbon nanotubes serves as a drug deliv...
Breaking Biology Technology:NOVAVAX to Present at the Piper Jaffray 21st Annual Health Care Conference 2NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 2NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 3NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 4WuXi PharmaTech Named in Deloitte Technology Fast 50 China 2009 List for the Fifth Consecutive Year 2North Carolina Based Cromoz Inc. Launches Carbon Nanotechnology for Target Drug Delivery System in Cancer Treatment in Hyderabad, India 2
...ty is changing but the way we think about work lif...f work does not work, but nobody is ready to trans...g serious implications for gender equality and lif...taken from a paper by Rhonda Rappaport, Suzan Lewi...fe Harmonization: Visions and Pragmatic Strategies...
...first came to the Wisconsin State Senate five ye...onsin had done little to transform its economy fro...urial model favoring innovation and ideas. , ,Simp... old jobs at the expense of creating new ones. The...he back of the line when it came to capital format...
... Wis. Third Wave Technologies Inc. , a Madison co...ic reagents for DNA and RNA analysis applications,... ,Napier,s background in general management and ma..., according to president and CEO Kevin T. Conroy. ...en,s markets in the promotion of products at Proc...
Other Biology Technology:Work-life imbalance - A global problem getting worse 2Work-life imbalance - A global problem getting worse 3Work-life imbalance - A global problem getting worse 4Work-life imbalance - A global problem getting worse 5It's time for Wisconsin's economy to grow 2It's time for Wisconsin's economy to grow 3Napier joins board of Third Wave Technologies 2
(Date:11/30/2009)... Conference on Systems & Enterprises (GCSE), to be...es on the convergence of complex large-scale syste...ty. , The goal of the conference is to build...complex systems, examined by domain, each successi...astructure Systems, including Intelligent/Smart In...
(Date:11/30/2009)...se scientists are presented with the complex chall...t. In a paper published in Insect Conservation an...r Miguel Rodriguez assess this challenge. , Twen...#730;C has already affected the Earth,s biota and ...utionary biologists is to predict how biological i...
(Date:11/30/2009)...he virus,s exquisite specialisation for its human ...like the humble lab mouse, can deliver only limite...in BioMed Central,s open access Journal of Biolog...by creating a mouse that has key features of HIV i...ge Kassiotis, from the Division of Immunoregulatio...
Breaking Biology News(10 mins):First global conference on systems and enterprises at new Stevens location, Washington, DC, Dec. 3-4 2How can scientists measure evolutionary responses to climate change? 2A reductionist approach to HIV research 2IncentOne Announces New Incentive Wrap Around to Increase Participation in Multi Flu Prevention Programs 52262 1IncentOne Announces New Incentive Wrap Around to Increase Participation in Multi Flu Prevention Programs 52262 2Healthplace America Names Todd Roscoe to New Position of Chief Managed Care Officer 52260 1Healthplace America Names Todd Roscoe to New Position of Chief Managed Care Officer 52260 2Healthplace America Names Todd Roscoe to New Position of Chief Managed Care Officer 52260 3Tips from the journals of the American Society for Microbiology 52258 1Tips from the journals of the American Society for Microbiology 52258 2Tips from the journals of the American Society for Microbiology 52258 3Tips from the journals of the American Society for Microbiology 52258 4
...l to understanding male infertility and could be u...ity treatments according to a paper published by t...P). The article demonstrates how proteomics, a rel...eins in a cell, can be successfully applied to inf... cells are dysfunctional. , "Up to 50 percent of ...
...e tools of chemistry and astronomy will use the un...study of basic chemistry from the restrictive bond...verse will allow scientists to explore new types o...conditions of space. The center will combine labo...-telescope observations to dramatically expand our...
...stem that could lead to more efficient and more di...s has been developed by biomedical engineers at Th...se specific ribonucleic acid (RNA) molecules to si...e tailoring it based on the type of immune respons... says Krishnendu Roy, associate professor of biome...
Other Biology News:Proteins in sperm unlock understanding of male infertility says new study 2Research center to free chemistry from Earth's bonds 2RNA molecules, delivery system improve vaccine responses, effectiveness 2
Synthetic Peptide Synthesis from rPeptide, LLC
Reverse Transcriptase AMV; RNA dependent DNA polymerase from Roche Applied Science
Shake 'n' Stack oven - New Model from Thermo Scientific
...Plus is a system designed for in vitro NSC expan...he kit contains a specially formulated N-2 Plus Me...l stem cell expansion (Johe, K.K. et al . (1996) ...rowth factor basic (FGF basic) is included to prom...
Biology Products: